A.M.P. Demandt

Lamberink, H., Huygens, S., Aerts, R., Lagrou, K., van Leeuwen-Segarceanu, E., Lodewyck, T., Nieuwenhuizen, L., Corsten, M. F., Moors, I., Servais, S., De Greef, J., Hites, M., Demandt, A., Schauwvlieghe, A., Maertens, J., & Rijnders, B. (2025). Superiority trials in invasive aspergillosis: a harsh reality check with the IA-DUET (HOVON502) trial. Clinical Infectious Diseases, 80(2), 367-370. https://doi.org/10.1093/cid/ciae501

van der Zwet, W. C., Klomp-Berens, E. A., Demandt, A. M. P., Dingemans, J., van der Veer, B. M. J. W., van Alphen, L. B., Dirks, J. A. M. C., & Savelkoul, P. H. M. (2024). Analysis of two sequential SARS-CoV-2 outbreaks on a haematology-oncology ward and the role of infection prevention. Infection Prevention in Practice, 6(1), Article 100335. https://doi.org/10.1016/j.infpip.2023.100335

Chamuleau, M. E. D., Stenner, F., Chitu, D. A., Novak, U., Minnema, M. C., Geerts, P., Stevens, W. B. C., Zenz, T., van Imhoff, G. W., Wu, K. L., Demandt, A. M. P., Kersten, M. J., Terpstra, W. E., Tick, L. W., Deeren, D., Van Den Neste, E., Gregor, M., Veelken, H., Böhmer, L. H., ... Lugtenburg, P. (2023). R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial. The Lancet Haematology, 10(12), E966-E975. https://doi.org/10.1016/S2352-3026(23)00279-X

van Baarle, F. L. F., van de Weerdt, E. K., van der Velden, W. J. F. M., Ruiterkamp, R. A., Tuinman, P. R., Ypma, P. F., van den Bergh, W. M., Demandt, A. M. P., Kerver, E. D., Jansen, A. J. G., Westerweel, P. E., Arbous, M. S., Determann, R. M., van Mook, W. N. K. A., Koeman, M., Mäkelburg, A. B. U., van Lienden, K. P., Vlaar, A. P. J., & Biemond, B. J. (2023). Predictors of the corrected count increment after platelet transfusion, a secondary analysis of the PACER randomized controlled trial. American Journal of Hematology, 98(11), E305-E308. https://doi.org/10.1002/ajh.27053

Huygens, S., Dunbar, A., Buil, J. B., Klaassen, C. H. W., Verweij, P. E., van Dijk, K., de Jonge, N., Janssen, J. J. W. M., van der Velden, W. J. F. M., Biemond, B. J., Bart, A., Bruns, A. H. W., Haas, P.-J. A., Demandt, A. M. P., Oudhuis, G., von dem Borne, P., van der Beek, M. T., Klein, S. K., Godschalk, P., ... Rijnders, B. J. A. (2023). Clinical Impact of Polymerase Chain Reaction-based Aspergillus and Azole Resistance Detection in Invasive Aspergillosis: A Prospective Multicenter Study. Clinical Infectious Diseases, 77(1), 38-45. https://doi.org/10.1093/cid/ciad141

van Baarle, F. L. F., van de Weerdt, E. K. K., van der Velden, W. J. F. M., Ruiterkamp, R. A. A., Tuinman, P. R. R., Ypma, P. F. F., van den Bergh, W. M. M., Demandt, A. M. P., Kerver, E. D. D., Jansen, A. J. G., Westerweel, P. E. E., Arbous, S. M. M., Determann, R. M. M., van Mook, W. N. K. A., Koeman, M., Makelburg, A. B. U., van Lienden, K. P. P., Binnekade, J. M. M., Biemond, B. J. J., & Vlaar, A. P. J. (2023). Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia. New England Journal of Medicine, 388(21), 1956-1965. https://doi.org/10.1056/NEJMoa2214322

Germeraad, R. S., Demandt, A. M. P., & Rouhl, R. P. W. (2022). Phenytoin as seizure prophylaxis in hematopoietic stem cell transplantation with busulfan conditioning. Frontiers in Neurology, 13, Article 928550. https://doi.org/10.3389/fneur.2022.928550

Iglói, Z., van Loo, I. H. M., Demandt, A. M. P., Franssen, K., Jonges, M., van Gelder, M., Erkens-Hulshof, S., & van Alphen, L. B. (2022). Controlling a human parainfluenza virus-3 outbreak in a haematology ward in a tertiary hospital: the importance of screening strategy and molecular diagnostics in relation to clinical symptoms. Journal of Hospital Infection, 126, 56-63. https://doi.org/10.1016/j.jhin.2022.03.017

van der Zwet, W. C., Nijsen, I. E. J., Jamin, C., van Alphen, L. B., von Wintersdorff, C. J. H., Demandt, A. M. P., & Savelkoul, P. H. M. (2022). Role of the environment in transmission of Gram-negative bacteria in two consecutive outbreaks in a haematology-oncology department. Infection Prevention in Practice, 4(2), Article 100209. https://doi.org/10.1016/j.infpip.2022.100209

van der Heiden, P. L. J., Arbous, M. S., van Beers, E. J., van den Bergh, W. M., le Cessie, S., Demandt, A. M. P., Eefting, M., Hess, C., Kusadasi, N., Marijt, W. A. F., van Mook, W. N. K. A., Mueller, M. C. A., Tuinman, P. R., van Vliet, M., van Westerloo, D. J., Blijlevens, N. M. A., & HEMA-ICU Study Group (2019). Predictors of short-term and long-term mortality in critically ill patients admitted to the intensive care unit following allogeneic stem cell transplantation. Bone Marrow Transplantation, 54(3), 418-424. https://doi.org/10.1038/s41409-018-0277-3